imatinib mesylate has been researched along with Budd-Chiari Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabane, J; Garderet, L; Josselin-Mahr, L; Werbrouck-Chiraux, A | 1 |
1 other study(ies) available for imatinib mesylate and Budd-Chiari Syndrome
| Article | Year |
|---|---|
Efficacy of imatinib mesylate in a case of Churg-Strauss syndrome: evidence for the pathogenic role of a tyrosine kinase?
Topics: Adult; Benzamides; Budd-Chiari Syndrome; Churg-Strauss Syndrome; Comorbidity; Female; Humans; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Treatment Outcome | 2014 |